






















![]()
Axogen, Inc. (AXGN) Bank of America Global Healthcare Conference 2026 May 13, 2026 12:35 PM EDT
Company Participants
Michael Dale - President, CEO & Director
Lindsey Hartley - Chief Financial Officer
Presentation
Unknown Analyst
[Audio Gap]
What do you think was most broken or underappreciated when you arrived?
Michael Dale
President, CEO & Director
So first of all, the big question, so why did I choose Axogen. And I do my best to convey whenever the question is asked, the criteria that I was trained on many years ago, and I've tried to use as a basic starting point. And first and foremost is what's the purpose of the business? Why does it exist? Is it fundamentally credible? Is it emotive? And so when you start to think about peripheral nerve function, it's very quick -- it's very easy to quickly conclude that, yes, this is a very credible health condition that if you can solve for, makes a difference. Second, is that particular situation that the business is focused upon numerous enough to justify the allocation of people, capital and time. And then finally, and most important of all, do you actually have a distinctive solution that is advantaged relative to other existing standard of care options.
And so if you have those 3 things, everything else is a functional exercise that you can adapt, adjust or build further upon to bring that value proposition forward. And when I was first learned about approach and learned about Axogen, I was able to quickly conclude that the purpose of the business was highly credible. It was a very numerous problem, grossly underserved, complex by virtue of the various care pathways, but nonetheless, clear in terms of the opportunity to treat patients.
And then finally, Avance as a platform as a foundation
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。